Papers/PMID:18555575
Chronic consumption of rebaudioside A, a steviol glycoside, in men and women with type 2 diabetes mellitus.
Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association2008The record
1 finding · 1 compound · 1 endpoint · 1 null
What it reported
How to read these marksEvery finding here is a null result.
What did not
1 finding
rebaudioside A — no detected effect on fasting blood glucose
Very limitedEvidence strength: very limited. Human evidence with major recorded weaknesses, or non-human, uncontrolled or unverified evidence.FindingNull result“Changes from baseline for rebaudioside A and placebo, respectively, in fasting glucose (7.5+/-3.7mg/dL and 11.2+/-4.5mg/dL), insulin (1.0+/-0.64microU/mL and 3.3+/-1.5microU/mL), and C-peptide (0.13+/-0.09ng/mL and 0.42+/-0.14ng/mL) did not differ significantly (p>0.05 for all).”
Quoted verbatim from Chronic consumption of rebaudioside A, a steviol glycoside, in men and women with type 2 diabetes mellitus.. - Study
- RCT
- Duration
- 4 months
- Dose
- 1000 mg rebaudioside A for 16 weeks
- Population
- men and women aged 33-75 years with type 2 diabetes mellitus
Chronic consumption of rebaudioside A, a steviol glycoside, in men and women with type 2 diabetes mellitus.2008PMID:18555575Permalink